Work

Haploidentical Transplantation for Advanced Hematologic Malignancies Using Melphalan-Based Conditioning – Mature Results from a Single Center

Year: 2014

Type: article

Abstract: Haploidentical stem cell transplantation (HaploSCT) using post-transplant cyclophosphamide (PTCY) has been performed primarily with non-myeloablative conditioning. We are exploring a melphalan-based, myeloablative yet reduced-intensity conditioning (RIC), in an ongoing phase II clinical trial.

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2013.12.033

Authors: Sai Ravi Pingali, Denai Milton, Antonio di Stasi, Rushang D. Patel, Partow Kebriaei, Uday R. Popat, Amin M. Alousi, Paolo Anderlini, Muzaffar H. Qazilbash, Chitra Hosing, Katy Rezvani, Qaiser Bashir, Betul Oran, Elizabeth J. Shpall, Issa F. Khouri, Richard E. Champlin, Stefan O. Ciurea

Institutions: The University of Texas MD Anderson Cancer Center, Temple University

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650

OpenAlex ID: W2139484649

FWCI: 0.943

Cites:

Cited by: 9

Related to: 10